Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1
- 8 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 37 (5), 1-11
- https://doi.org/10.1007/s12032-020-01366-w
Abstract
Breast cancer is the most common cancer in women. Although several studies demonstrated cellular apoptosis susceptibility protein (CAS) involved in the development of breast cancer, the underlying mechanisms of CAS regulating cell processes in the breast cancer remain elusive. In the present study, we explored the possible mechanism of CAS in contributing to the cell proliferation in the breast cancer cell line MCF-7. Knockdown of CAS led to the reduction of cell viability and proliferation. Furthermore, cell cycle was arrested in G0/G1 phase after knocking down CAS with the decrease of cyclinD1. In addition, RNA-seq analysis for the CAS knockdown cells demonstrated that total eleven genes were significantly altered (Fold changes > 2). Of note, the expression of cyp24a1 was dramatically increased in the shCAS cells compared to that of shNC cells as well as confirmed by quantitative real-time polymerase chain reaction (qPCR). These observations clarified the previous conflicting results on the cell fates of the breast cells regulated by CAS and provide new insight into the role of CAS in the development of breast cancer.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFC1003602)
- National Natural Science Foundation of China (81671432, 81871202)
- the startup R&D funding of Nantong University (03083011)
This publication has 52 references indexed in Scilit:
- Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stageJournal of Translational Medicine, 2013
- CYP24A1 Exacerbated Activity during Diabetes Contributes to Kidney Tubular Apoptosis via Caspase-3 Increased Expression and ActivationPLOS ONE, 2012
- CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung AdenocarcinomaClinical Cancer Research, 2011
- Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cellsExperimental Cell Research, 2010
- Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosisJournal of Experimental & Clinical Cancer Research, 2010
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal TumorigenesisJournal of Histochemistry & Cytochemistry, 2009
- Higher Prevalence of Secretory CSE1L/CAS in Sera of Patients with Metastatic CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patientsBreast Cancer Research and Treatment, 2008
- CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cellsJournal of Experimental & Clinical Cancer Research, 2008